Which of the following statements regarding agents used to treat Type 2 diabetes mellitus is FALSE?
A. Metformin is contraindicated in patients with an eGFR of less than 60 mL/min/1.73 m2 Correct Choice
B. Sodium-glucose co-transporter 2 (SGLT2) inhibitors can cause hypovolemia and acute kidney injury Wrong Choice!
C. Sulfonylureas reduce both microvascular and macrovascular complications of diabetes Wrong Choice!
D. Both glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors are associated with acute pancreatitis Wrong Choice!
Answer:A
Which of the following statements regarding agents used to treat Type 2 diabetes mellitus is FALSE?
A. Metformin is contraindicated in patients with an eGFR of less than 60 mL/min/1.73 m2 Correct Choice B. Sodium-glucose co-transporter 2 (SGLT2) inhibitors can cause hypovolemia and acute kidney injury Wrong Choice! C. Sulfonylureas reduce both microvascular and macrovascular complications of diabetes Wrong Choice! D. Both glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors are associated with acute pancreatitis Wrong Choice!